Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* GSK talking to regulators about potential approval* Injection 69% more effective than daily Truvada pill* GSK likely to face market flooded by cheap Truvada copies (Adds quote from ViiV executive, shares, analyst comment)By Ludwig BurgerMay 18 (Re...
Read more* GSK talking to regulators about potential approval* Injection 69% more effective than daily Truvada pill* GSK likely to face market flooded by cheap Truvada copies (Adds background on future market opportunity)By Ludwig BurgerMay 18 (Reuters) - Gl...
Read more
(Sharecast News) - GlaxoSmithKline said on Monday that ViiV Healthcare, in which it owns a majority stake, is ending a study early after finding that its long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral pre-exposure prophylaxis (PrEP) in preventing HIV transmission.
Read more
UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell
Read more(Adds background)WASHINGTON, May 13 (Reuters) - President Donald Trump is expected to tap a former GlaxoSmithKline executive and a U.S. general to spearhead the government's effort at developing a coronavirus vaccine on an accelerated schedule, of...
Read moreWASHINGTON, May 13 (Reuters) - President Donald Trump is expected to tap a former GlaxoSmithKline executive and a U.S. general to spearhead the government's effort at developing a coronavirus vaccine on an accelerated schedule, officially called ...
Read more* European shares slump on virus fears* Banks hit by earnings* EZ industry output suffers record fall in March Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thou...
Read more* European shares slump on virus fears* Banks hit by earnings* EZ industry output suffers record fall in March Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thou...
Read more(Adds background, mode of action, previous pacts)By Ludwig BurgerMay 7 (Reuters) - GlaxoSmithKline will start trials of an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 at the end of the month.Havi...
Read moreUK DIRECTOR DEALINGS SUMMARY: ThinkSmart Non-Exec Buys 500,000 Shares
Read more(Sharecast News) - GlaxoSmithKline announced a rise in the proceeds it was expecting from the sale of its Indian consumer healthcare portfolio on Thursday, as it sold its holding in Hindustan Unilever.
Read moreGlaxoSmithKline's Hindustan Unilever Shares To Reap More Than Expected
Read more* GSK cashes in after 2018 Horlicks divestment* Sells 5.7% stake in Unilever's India business* GSK had folded Horlicks unit into Hindustan Unilever (Updates with HUL share price, book runner details)By Scott Murdoch and Anshuman DagaHONG KONG/SINGAP...
Read more* GSK cashes in after 2018 Horlicks divestment* Sells 5.7% stake in Unilever's India business* GSK had folded Horlicks unit into Hindustan Unilever (Adds details of share sale)By Scott Murdoch and Anshuman DagaHONG KONG/SINGAPORE, May 7 (Reuters) - ...
Read more
Last checked at